SNTI Acquisition: a negative outcome, -10.5%

On October 26, 2026, Senti Biosciences, Inc. reached its Acquisition. The result was a negative outcome, and the stock moved -10.5% in the window around the event. It had already run -42.4% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.